ProKidney CorpNASDAQ:PROK
- LAST PRICE1.8300
- TODAY'S CHANGE (%)0.1400 (8.2840%)
- Bid / Lots1.8100/ 2
- Ask / Lots1.8700/ 2
- Open / Previous Close1.7300 / 1.6900
- Day Range
- 52 Week Range
- Volume380,311
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PROK |
|---|---|---|
| 09:32 ET | 6364 | 1.7295 |
| 09:33 ET | 5579 | 1.77 |
| 09:35 ET | 3568 | 1.7611 |
| 09:37 ET | 2000 | 1.7646 |
| 09:39 ET | 1097 | 1.775 |
| 09:42 ET | 3249 | 1.79 |
| 09:44 ET | 8868 | 1.79 |
| 09:46 ET | 800 | 1.79 |
| 09:48 ET | 1230 | 1.8 |
| 09:50 ET | 3620 | 1.79 |
| 09:51 ET | 5073 | 1.7801 |
| 09:53 ET | 3207 | 1.76 |
| 09:55 ET | 7672 | 1.725 |
| 09:57 ET | 576 | 1.735 |
| 10:00 ET | 344 | 1.73 |
| 10:02 ET | 3730 | 1.7479 |
| 10:04 ET | 561 | 1.75 |
| 10:06 ET | 9385 | 1.745 |
| 10:08 ET | 3452 | 1.755 |
| 10:11 ET | 887 | 1.745 |
| 10:13 ET | 1340 | 1.7306 |
| 10:15 ET | 1100 | 1.715 |
| 10:18 ET | 2345 | 1.72 |
| 10:20 ET | 910 | 1.725 |
| 10:22 ET | 1000 | 1.735 |
| 10:24 ET | 1140 | 1.735 |
| 10:26 ET | 120 | 1.735 |
| 10:27 ET | 2952 | 1.7606 |
| 10:29 ET | 300 | 1.765 |
| 10:31 ET | 154 | 1.77 |
| 10:36 ET | 100 | 1.775 |
| 10:42 ET | 150 | 1.7894 |
| 10:45 ET | 1000 | 1.795 |
| 10:47 ET | 800 | 1.7904 |
| 10:54 ET | 100 | 1.795 |
| 10:56 ET | 4758 | 1.795 |
| 10:58 ET | 850 | 1.795 |
| 11:00 ET | 1832 | 1.8 |
| 11:02 ET | 6467 | 1.8 |
| 11:12 ET | 3800 | 1.79 |
| 11:14 ET | 200 | 1.785 |
| 11:16 ET | 3463 | 1.785 |
| 11:20 ET | 200 | 1.79 |
| 11:30 ET | 1141 | 1.7806 |
| 11:32 ET | 1825 | 1.77 |
| 11:36 ET | 1149 | 1.765 |
| 11:38 ET | 273 | 1.7598 |
| 11:39 ET | 1000 | 1.76 |
| 11:41 ET | 23412 | 1.8 |
| 11:43 ET | 3413 | 1.81 |
| 11:50 ET | 200 | 1.8099 |
| 11:54 ET | 7645 | 1.83 |
| 11:56 ET | 3400 | 1.845 |
| 11:59 ET | 100 | 1.855 |
| 12:01 ET | 139 | 1.86 |
| 12:03 ET | 5415 | 1.855 |
| 12:06 ET | 800 | 1.865 |
| 12:10 ET | 6000 | 1.865 |
| 12:12 ET | 300 | 1.865 |
| 12:14 ET | 6132 | 1.855 |
| 12:15 ET | 100 | 1.855 |
| 12:24 ET | 336 | 1.855 |
| 12:30 ET | 400 | 1.855 |
| 12:32 ET | 10624 | 1.825 |
| 12:35 ET | 1371 | 1.83 |
| 12:37 ET | 418 | 1.825 |
| 12:39 ET | 300 | 1.825 |
| 12:44 ET | 2885 | 1.815 |
| 12:46 ET | 100 | 1.815 |
| 12:48 ET | 100 | 1.815 |
| 12:50 ET | 2905 | 1.805 |
| 12:51 ET | 250 | 1.8025 |
| 12:53 ET | 141 | 1.805 |
| 12:55 ET | 1239 | 1.815 |
| 01:02 ET | 372 | 1.825 |
| 01:04 ET | 100 | 1.825 |
| 01:08 ET | 1956 | 1.815 |
| 01:09 ET | 100 | 1.815 |
| 01:13 ET | 1000 | 1.82 |
| 01:15 ET | 3933 | 1.84 |
| 01:18 ET | 1286 | 1.845 |
| 01:22 ET | 4372 | 1.8408 |
| 01:24 ET | 336 | 1.845 |
| 01:26 ET | 318 | 1.845 |
| 01:29 ET | 735 | 1.845 |
| 01:31 ET | 400 | 1.845 |
| 01:33 ET | 200 | 1.85 |
| 01:36 ET | 300 | 1.86 |
| 01:38 ET | 100 | 1.855 |
| 01:40 ET | 500 | 1.855 |
| 01:42 ET | 413 | 1.855 |
| 01:44 ET | 687 | 1.855 |
| 01:45 ET | 1523 | 1.845 |
| 01:47 ET | 100 | 1.845 |
| 01:49 ET | 100 | 1.845 |
| 01:51 ET | 700 | 1.855 |
| 01:54 ET | 350 | 1.855 |
| 01:56 ET | 200 | 1.855 |
| 01:58 ET | 2259 | 1.8488 |
| 02:00 ET | 600 | 1.845 |
| 02:02 ET | 1000 | 1.845 |
| 02:03 ET | 1200 | 1.835 |
| 02:07 ET | 899 | 1.845 |
| 02:09 ET | 2100 | 1.845 |
| 02:12 ET | 808 | 1.865 |
| 02:16 ET | 100 | 1.865 |
| 02:18 ET | 940 | 1.86 |
| 02:20 ET | 200 | 1.865 |
| 02:21 ET | 100 | 1.865 |
| 02:25 ET | 1829 | 1.855 |
| 02:27 ET | 200 | 1.855 |
| 02:32 ET | 200 | 1.855 |
| 02:34 ET | 100 | 1.855 |
| 02:38 ET | 100 | 1.855 |
| 02:41 ET | 500 | 1.855 |
| 02:43 ET | 700 | 1.855 |
| 02:45 ET | 100 | 1.855 |
| 02:48 ET | 300 | 1.855 |
| 02:50 ET | 200 | 1.855 |
| 02:52 ET | 100 | 1.855 |
| 02:54 ET | 400 | 1.855 |
| 02:56 ET | 100 | 1.855 |
| 02:57 ET | 500 | 1.855 |
| 02:59 ET | 269 | 1.86 |
| 03:01 ET | 200 | 1.855 |
| 03:03 ET | 200 | 1.855 |
| 03:06 ET | 1890 | 1.845 |
| 03:08 ET | 788 | 1.845 |
| 03:10 ET | 900 | 1.855 |
| 03:12 ET | 690 | 1.8501 |
| 03:14 ET | 100 | 1.855 |
| 03:15 ET | 105 | 1.8599 |
| 03:17 ET | 522 | 1.86 |
| 03:19 ET | 200 | 1.865 |
| 03:21 ET | 700 | 1.87 |
| 03:24 ET | 1200 | 1.865 |
| 03:28 ET | 400 | 1.865 |
| 03:32 ET | 200 | 1.865 |
| 03:33 ET | 2068 | 1.875 |
| 03:35 ET | 4285 | 1.88 |
| 03:37 ET | 400 | 1.875 |
| 03:39 ET | 7652 | 1.87 |
| 03:42 ET | 6773 | 1.8593 |
| 03:44 ET | 100 | 1.855 |
| 03:46 ET | 500 | 1.855 |
| 03:48 ET | 1548 | 1.855 |
| 03:50 ET | 1766 | 1.85 |
| 03:51 ET | 900 | 1.845 |
| 03:53 ET | 800 | 1.845 |
| 03:55 ET | 1300 | 1.845 |
| 03:57 ET | 2324 | 1.835 |
| 04:00 ET | 61542 | 1.83 |
Nov 12, 2024
ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting, from 7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:30AM ET on Tuesday Nov 12, 2024 by Dow JonesPress Release: ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting, from 7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 5, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ProKidney Corp | 489.6M | -3.3x | --- |
Terns Pharmaceuticals Inc | 488.7M | -4.9x | --- |
Celcuity Inc | 488.4M | -5.3x | --- |
Korro Bio Inc | 486.4M | -3.1x | --- |
Opthea Ltd | 484.9M | -1.1x | --- |
GH Research PLC | 482.3M | 0.0x | --- |
Company Information
ProKidney Corp. is a clinical-stage biotechnology company. The Company is focused on cell therapy platforms capable of treating multiple chronic kidney diseases (CKD) using a patient’s own cells isolated from the patient intended for treatment. The Company’s lead product candidate, Renal Autologous Cell Therapy (REACT), is designed to preserve kidney function in a CKD patient’s diseased kidneys. REACT is a product that includes autologous Selected Renal Cells (SRCs) prepared from a patient’s own (autologous) kidney cells. The REACT injection is an investigational therapy that is a mixture of kidney cells prepared from the participant’s own kidney tissue. Its patented technology includes multiple breakthroughs in the manufacturing and medical delivery of cellular therapy products. It is conducting a global Phase 3 development program and multiple Phase 2 clinical trials for REACT in subjects with moderate to severe diabetic kidney disease (DKD).
Contact Information
- Headquarters
- 2000 Frontis Plaza Blvd., Suite 250WINSTON-SALEM, NC, United States 27103
- Phone
- 336-999-7028
- Fax
- ---
Executives
- Chairman of the Board
- Pablo Legorreta
- Chief Executive Officer, Director
- Bruce Culleton
- Chief Financial Officer
- James Coulston
- Executive Vice President - Technical Operations
- Ulrich Ernst
- Senior Vice President - Global Clinical Operations
- Lucio Tozzi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $489.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 289.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.31 |
EPS | $-0.55 |
Book Value | $-4.84 |
P/E Ratio | -3.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
